Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 11, 2011, Pages 1437-1441

  Borghi, E ^a   Sciota, R ^a   Iatta, R ^b   Biassoni, C ^a   Montagna, M T ^b   Morace, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC MYCOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DEHYDROGENASE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; ECHINOCANDINS; FUNGAL PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; ITALY; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; TRIAZOLES; YOUNG ADULT;

EID: 80054731656     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1242-x     Document Type: Article

References (23)

1. G St-Germain M Laverdière R Pelletier, et al. 2008 Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005 Can J Infect Dis Med Microbiol 19 55 62 19145263 (Pubitemid 351547673)
2. SJ van Hal DJ Marriott SC Chen Australian Candidaemia Study, et al. 2009 Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience Transpl Infect Dis 11 122 127 19220822 10.1111/j.1399-3062.2009.00371.x
3. P Eggimann J Garbino D Pittet 2003 Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect Dis 3 685 702 14592598 10.1016/S1473-3099(03)00801-6 (Pubitemid 37345347)
4. AF Shorr DR Lazarus JH Sherner, et al. 2007 Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia Crit Care Med 35 1077 1083 17312565 10.1097/01.CCM.0000259379.97694.00 (Pubitemid 46598958)
5. AM Tortorano E Biraghi A Astolfi FIMUA Candidemia Study Group, et al. 2002 European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region J Hosp Infect 51 297 304 12183145 10.1053/jhin.2002.1261 1:STN:280:DC%2BD38vis1GltQ%3D%3D (Pubitemid 38001880)
6. B Almirante D Rodríguez M Cuenca-Estrella, et al. 2006 Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 44 1681 1685 16672393 10.1128/JCM.44.5.1681-1685.2006 (Pubitemid 43726255)
7. MA Pfaller DJ Diekema 2007 Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 133 163 17223626 10.1128/CMR.00029-06 1:CAS:528:DC%2BD2sXhvFKnur0%3D (Pubitemid 46167771)
8. JH Shin SJ Kee MG Shin, et al. 2002 Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources J Clin Microbiol 40 1244 1248 11923339 10.1128/JCM.40.4.1244-1248.2002 (Pubitemid 34279883)
9. A Tavanti AD Davidson NA Gow, et al. 2005 Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III J Clin Microbiol 43 284 292 15634984 10.1128/JCM.43.1.284-292.2005 1:CAS:528:DC%2BD2MXhtF2nurY%3D (Pubitemid 40096313)
10. SS Gonçalves CS Amorim M Nucci, et al. 2010 Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil Clin Microbiol Infect 16 885 887 10.1111/j.1469-0691.2009.03020.x 19686280
11. Barcelona Candidemia Project Study Group A Gomez-Lopez A Alastruey-Izquierdo D Rodríguez, et al. 2008 Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain Antimicrob Agents Chemother 52 1506 1509 18285486 10.1128/AAC.01595-07 1:CAS:528: DC%2BD1cXksFajtLc%3D (Pubitemid 351522020)
12. SR Lockhart SA Messer MA Pfaller, et al. 2008 Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis J Clin Microbiol 46 2659 2664 18562582 10.1128/JCM.00803-08 1:CAS:528:DC%2BD1cXhtVyms73O
13. Z Szabó J Szilágyi A Tavanti, et al. 2009 In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology Diagn Microbiol Infect Dis 64 283 288 19394787 10.1016/j.diagmicrobio.2009.03.011
14. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd edn. Approved standard M27-205 A3. CLSI, Wayne, PA
15. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts-Third Informational Supplement, M27-S3. CLSI, Wayne, PA
16. MA Pfaller M Castanheira SA Messer, et al. 2011 Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009) Diagn Microbiol Infect Dis 69 45 50 21146713 10.1016/j.diagmicrobio.2010.08.013 1:CAS:528:DC%2BC3cXhsFCru7jL
17. MA Pfaller DJ Diekema RN Jones, et al. 2002 Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 J Clin Microbiol 40 852 856 11880404 10.1128/JCM.40.3.852-856.2002 1:CAS:528:DC%2BD38XisVKrs74%3D (Pubitemid 34208634)
18. MA Pfaller L Boyken RJ Hollis, et al. 2010 Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol 48 52 56 19923478 10.1128/JCM.01590-09 1:CAS:528:DC%2BC3cXhvFKqtLY%3D
19. AP Silva IM Miranda C Lisboa, et al. 2009 Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital J Clin Microbiol 47 2392 2397 19494078 10.1128/JCM.02379-08 1:CAS:528:DC%2BD1MXhtVyhurvI
20. MJ Jacobson KE Piper G Nguyen, et al. 2008 In vitro activity of anidulafungin against Candida albicans biofilms Antimicrob Agents Chemother 52 2242 2243 18391031 10.1128/AAC.00211-08 1:CAS:528:DC%2BD1cXmvVaitL8%3D (Pubitemid 351758568)
21. J Pemán E Cantón A Valentín 2008 Activity of anidulafungin against Candida biofilms [in Spanish] Rev Iberoam Micol 25 124 128 18473507 10.1016/S1130-1406(08)70030-5 (Pubitemid 351798340)
22. A Katragkou A Chatzimoschou M Simitsopoulou, et al. 2008 Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms Antimicrob Agents Chemother 52 357 360 17938192 10.1128/AAC.00856-07 1:CAS:528:DC%2BD1cXkslelsg%3D%3D
23. G Garcia-Effron SK Katiyar S Park, et al. 2008 A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility Antimicrob Agents Chemother 52 2305 2312 18443110 10.1128/AAC.00262-08 1:CAS:528:DC%2BD1cXot1Oitrg%3D (Pubitemid 351915657)